Nan Chen

Dr. Nan Chen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
GZGuozhong Zhou
Guozhong Zhou
WSWei Shi
Wei Shi
WSWeili Shi
Weili Shi
MHMeijun Hu
Meijun Hu
NCNan Chen
Nan Chen
Background: QuantiFERON-TB Gold Plus (QFT-Plus) is an important test that has emerged in recent years for detecting TB infection. We conducted a review to compare the sensitivity, specificity and positive rate of QFT-Plus with that of QuantiFERON-TB Gold In-Tube (QFT-GIT), T-cell spot of tuberculosis assay (T-SPOT.TB) and Tuberculin test (TST).Methods: PubMed and Embase were searched, without language restrictions, from 1 January 2015 to 31 March 2022 using “Mycobacterium tuberculosisInfections” and “QuantiFERON-TB-Plus” as search phrases. We estimated the sensitivity from studies of patients with active tuberculosis, specificity from studies of populations with very low risk of TB exposure, and positive rate from studies of high-risk populations. The methodological quality of the eligible studies was assessed, and a random-effects model meta-analysis was used to determine the risk difference (RD). We assessed the pooled rate by using a random-effects model. This study was registered in PROSPERO (CRD 42021267432).Results: Of 3996 studies, 83 were eligible for full-text screening and 41 were included in the meta-analysis. In patients with active TB, the sensitivity of QFT-Plus was compared to that of QFT-GIT and T-SPOT.TB, respectively, and no statistically differences were found. In populations with a very low risk of TB exposure, the specificity of QFT-Plus was compared with that of QFT-GTI and T-SPOT.TB, respectively, and no statistically differences were found. Two studies were eligible to compare the specificity of the QFT-Plus test with that of the TST test, and the pooled RD was 0.12 (95% CI 0.02 to 0.22). In high-risk populations, 18 studies were eligible to compare the positive rate of the QFT-Plus test with that of the QFT-GIT test, and the pooled RD was 0.02 (95% CI 0.01 to 0.03). The positive rate of QFT-Plus was compared with that of T-SPOT.TB and TST groups, and no statistically differences were found.Conclusions: The diagnostic performance of QFT-Plus was similar to that of QFT-GIT and T-SPOT.TB, but was slightly more specific than TST.

8 November 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
GZGuozhong Zhou
Guozhong Zhou
XGXin Guo
Xin Guo
SCShunli Cai
Shunli Cai
YZYu Zhang
Yu Zhang
YZYuanyuan Zhou
Yuanyuan Zhou
CSChao Song
Chao Song
Background: Previous studies have demonstrated an association between diabetes mellitus (DM) and latent tuberculosis infection (LTBI). This study was conducted to update the current understanding of the association between DM and LTBI. By conducting a systematic review and meta-analysis using adjusted odds ratios (aOR) or risk ratios (aRR), we aimed to further explore the association between DM and LTBI and provide essential reference for future research. Methods: We conducted comprehensive searches in Embase, Cochrane Library, and PubMed without imposing any start date or language restrictions, up to July 19, 2022. Our study selection encompassed observational research that compared from LTBI positive rates in both DM and non-DM groups and reported aRR or aOR results. The quality of the included studies was assessed utilizing the Newcastle–Ottawa Scale. Pooled effect estimates were calculated using random-effects models, along with their associated 95% confidence intervals (CI). Results: We included 22 studies involving 68,256 subjects. Three cohort studies were eligible, with a pooled aRR of 1.26 (95% CI: 0.71–2.23). Nineteen cross-sectional studies were eligible, with a pooled aOR of 1.21 (95% CI: 1.14–1.29). The crude RR (cRR) pooled estimate for three cohort studies was 1.62 (95% CI: 1.03–2.57). Among the cross-sectional studies we included, sixteen studies provided crude ORs, and the crude OR (cOR) pooled estimate was 1.64 (95% CI: 1.36–1.97). In the diagnosis of diabetes, the pooled aOR of the HbA1c group was higher than that of self-reported group (pooled aOR: 1.56, 95% CI: 1.24–1.96 vs. 1.17, 95% CI: 1.06–1.28). Conclusion: Our systematic review and meta-analysis suggest a positive association between DM and LTBI. Individuals with DM may have a higher risk of LTBI compared to those without DM. These findings provide important insights for future research and public health interventions in managing LTBI in diabetic populations.

7 April 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
GZGuozhong Zhou
Guozhong Zhou
WSWei Shi
Wei Shi
WSWeili Shi
Weili Shi
MHMeijun Hu
Meijun Hu
NCNan Chen
Nan Chen
Clear cell renal cell carcinoma (ccRCC) is a primary malignant tumour of tubular epithelial origin and is most common in the urinary tract. Growing evidence suggests that oxidative stress (OS), generates high levels of reactive oxygen species (ROS) and free radicals, and plays a critical role in cancer in humans. However, the predictive value of OS-related long non-coding RNAs (lncRNAs) in ccRCC remains unclear. We constructed a predictive signature of survival based on OS-related lncRNAs that were obtained from The Cancer Genome Atlas (TCGA–KIRC), to predict the prognosis of patients with ccRCC. The signature comprised seven lncRNAs: SPART-AS1, AL162586.1, LINC00944, LINC01550, HOXB-AS4, LINC02027, and DOCK9-DT. OS-related signature of lncRNAs had diagnostic efficiency higher than that of clinicopathological variables, with an area of 0.794 under the receiver operating characteristic curve. Additionally, the nomogram based on risk scores and clinicopathological variables (age, gender, grade, stage, M-stage, and N-stage) showed strong predictive performance. Patients with high-risk were found to be more sensitive to the therapeutic drugs ABT.888, AICAR, MS.275, sunitinib, AZD.2281, and GDC.0449. Our constructed the predictive signature can independently predict the prognosis of patients with ccRCC; however, the underlying mechanism needs further investigation.

9 May 2025 in Endokrynologia Polska
Verified
Journal Article
Open access
PDF file
SWSong Wen
Song Wen
XHXingjie Huang
Xingjie Huang
ZHZehan Huang
Zehan Huang
ZDZhexuan Deng
Zhexuan Deng
CZChao Zhou
Chao Zhou
HYHUANG Yu-qing
HUANG Yu-qing
Introduction: The relationship between changes in metabolic score for insulin resistance (METS-IR) and diabetes mellitus (DM) remains to be elucidated. The present study sought to explore whether changes in METS-IR were associated with incident DM. Material and methods: This study included 4031 individuals aged over 45 years from the China Health and Retirement Longitudinal Study. Utilizing the K-Means clustering method, participants were divided into four groups. Cumulative METS-IR was employed as a quantitative indicator reflecting changes in METS-IR. Multivariable logistic regression models and restricted cubic splines (RCS) were employed to assess the relationship between changes in METS-IR and DM. Results: During the five-year follow-up, 338 (8.4%) incident DM cases were identified. After adjusting for potential confounders, compared to class 1, the incident DM was significantly higher in class 4 [odds ratio (OR): 2.731, 95% confidence interval (CI): 1.411–5.527, p = 0.003]. When cumulative METS-IR (per SD increase) was introduced as a continuous variable into the multivariate regression model, the association remained significant in Model 3 (OR: 1.393, 95% CI: 1.125–1.715, p = 0.003). Additionally, when cumulative METS-IR was categorized into quartiles, compared to the first quartile, the incident DM was significantly higher in the fourth quartile (OR: 2.022, 95% CI: 1.171–3.501, p = 0.011). In addition, cumulative METS-IR exhibited a nonlinear association with DM (poverall = 0.001, pnon linear = 0.038). Conclusions: Substantial changes in METS-IR were independently associated with the risk of DM in middle-aged and elderly Chinese people. Long-term METS-IR monitoring is significant for early identification and prevention of DM, with significant implications for clinical practice. Keywords: metabolic score for insulin resistance diabetes mellitus China Health and Retirement Longitudinal Study cohort study elderly population

1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
HWHuabin Wang
Huabin Wang
RYRu Yang
Ru Yang
NCNan Chen
Nan Chen
XLXiang Li
Xiang Li
Objective: Hypoxia–glycolysis–lactylation (HGL) may play a crucial role in neonatal sepsis (NS). This study aims to identify HGL marker genes in NS and explore immune microenvironment among NS subtypes. Materials and Methods: The gene expression dataset GSE69686, comprising 64 NS cases and 85 controls, was selected for analysis. Based on the screened HGL‐related marker genes, diagnostic prediction models were constructed using nine machine learning algorithms, and molecular subtypes of NS were identified through consensus clustering. Subsequently, the heterogeneity of biological functions and immune cell infiltration among the different subtypes was analyzed. Finally, the marker genes and lactylation were validated using the GSE25504 dataset, clinical samples, and mouse neutrophil, respectively. Results: MERTK, HK3, PGK1, and STAT3 were identified and validated as marker genes, and the diagnostic prediction model for NS constructed using the support vector machine (SVM) algorithm exhibited optimal predictive performance. Based on gene expression patterns, two distinct NS subtypes were identified. Functional enrichment analysis highlighted significant immune‐related pathways, while immune infiltration analysis revealed differences in neutrophil proportions between the subtypes. Furthermore, the expression levels of marker genes were positively correlated with neutrophil infiltration. Importantly, the experimental validation results were consistent with the findings from the bioinformatics analysis. Conclusion: This study identified the distinct NS subtypes and their associated marker genes. These findings will contribute to elucidating the disease’s heterogeneity and establishing appropriate personalized therapeutic approaches.

10 March 2026 in Metabolism Open
Verified
Journal Article
Open access
XHXingjie Huang
Xingjie Huang
FHFeihuang Han
Feihuang Han
JXJiquan Xiao
Jiquan Xiao
QWQiheng Wan
Qiheng Wan
DMDunliang Ma
Dunliang Ma
SWSong Wen
Song Wen
Diabetes mellitus (DM) is a major global health burden. Insulin resistance (IR) is a key driver, but its direct assessment is often impractical in large-scale settings. The triglyceride-glucose (TyG) index and body roundness index (BRI) have emerged as accessible markers for IR and obesity, respectively. However, their combined role in predicting DM incidence remains unclear. This study aimed to evaluate the relationship between the TyG-BRI and DM risk, to provide a practical tool for early identification of high-risk individuals. This study included 15,310 Japanese adults who participated in the NAGALA Physical Examination Project from 2004 to 2015. To assess the association of TyG-BRI with DM incidence, Cox proportional-hazards regression model, restricted cubic spline (RCS) regression analyses, subgroup analyses, and sensitivity analyses were utilized. Time-dependent receiver operating characteristic (ROC) curve analysis was used to assess the ability of TyG-BRI to predict DM. To investigate the relationship between combined exposure to each component of TyG-BRI and DM incidence, weighted quantile sum regression analysis was employed. During the median 5.4-year follow-up duration, 350 (2.3%) participants developed DM. With TyG-BRI as a continuous variable, the HR (95% CI) for DM incidence was 1.38 (1.19-1.61) in the fully adjusted model. Participants with the highest TyG-BRI quartiles exhibited a 98% (HR 1.98, 95% CI 1.10-3.57) increased risk of DM compared to those with the lowest quartiles. RCS analysis indicated a positive linear relationship between TyG-BRI and DM incidence (p for overall<0.001; p for nonlinear = 0.465). FPG emerged as the primary contributor when the weights were assigned to the constituent elements of the TyG-BRI (weight = 0.751). Time-dependent ROC analyses suggested that TyG-BRI demonstrated superior and more stable predictive capacity for incident DM compared with the TyG index and BRI over mid-to long-term follow-up. The TyG-BRI was positively associated with the risk of DM, demonstrating a dose-response relationship. Maintaining lower TyG-BRI levels may be beneficial to reduce the burden of DM.